Literature DB >> 14997033

Lipopolysaccharide induces CD25-positive, IL-10-producing lymphocytes without secretion of proinflammatory cytokines in the human colon: low MD-2 mRNA expression in colonic macrophages.

Yuko Shirai1, Masahito Hashimoto, Rie Kato, Yuki I Kawamura, Teruo Kirikae, Hideaki Yano, Junya Takashima, Yujiro Kirihara, Yukio Saito, Masayuki A Fujino, Taeko Dohi.   

Abstract

Despite the huge number of colonized Gram-negative bacteria in the colon, the normal colon maintains its homeostasis without any excessive immune response. To investigate the potential mechanisms involved, human colonic lamina propria mononuclear cells (LPMCs) obtained from uninflamed mucosa were cultured with lipopolysaccharide (LPS) prepared from Bacteroides vulgatus (BV-LPS) or Bacteroides fragilis (BF-LPS), as representatives of indigenous flora, or pathogenic Salmonella minnesota (SM-LPS). Colonic LPMCs failed to produce inflammatory cytokines in response to any type of LPS. Colonic macrophages barely expressed mRNA for MD-2, an essential association molecule for LPS signaling via Toll-like receptor 4. Further, BV-LPS induced CD25 and Foxp3 expression in lymphocytes and CD4(+)CD25(+) cells expressed IL-10 mRNA. Thus, the low expression of functioning LPS receptor molecules and induction of IL-10-producing CD4(+)CD25(+) lymphocytes by indigenous LPS may play a central role in the maintenance of colonic immunological homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997033     DOI: 10.1023/B:JOCI.0000018062.01980.ba

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  49 in total

1.  Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities.

Authors:  P D Smith; L E Smythies; M Mosteller-Barnum; D A Sibley; M W Russell; M Merger; M T Sellers; J M Orenstein; T Shimada; M F Graham; H Kubagawa
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

2.  Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors.

Authors:  J S Gerber; D M Mosser
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Human Toll-like receptor 4 recognizes host-specific LPS modifications.

Authors:  Adeline M Hajjar; Robert K Ernst; Jeff H Tsai; Christopher B Wilson; Samuel I Miller
Journal:  Nat Immunol       Date:  2002-03-25       Impact factor: 25.606

4.  Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes.

Authors:  T Mattern; A Thanhäuser; N Reiling; K M Toellner; M Duchrow; S Kusumoto; E T Rietschel; M Ernst; H Brade; H D Flad
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

Review 5.  Endotoxin tolerance: a review.

Authors:  Michael A West; Wyrta Heagy
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

6.  T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.

Authors:  R Duchmann; E May; M Heike; P Knolle; M Neurath; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

7.  Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes.

Authors:  H L Dickensheets; S L Freeman; M F Smith; R P Donnelly
Journal:  Blood       Date:  1997-11-15       Impact factor: 22.113

8.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

9.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

10.  The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.

Authors:  T Bamba; H Matsuda; M Endo; Y Fujiyama
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

View more
  6 in total

1.  Specific messenger RNA expression for signal transduction molecules by lipopolysaccharide in intestinal macrophages.

Authors:  K Nakata; H Inagawa; T Nishizawa; C Kohchi; G-I Soma
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

2.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

3.  PGE2 Inhibits IL-10 Production via EP2-Mediated β-Arrestin Signaling in Neuroinflammatory Condition.

Authors:  Chun-Hsien Chu; Shih-Heng Chen; Qingshan Wang; Robert Langenbach; Hong Li; Darryl Zeldin; Shiou-Lan Chen; Shijun Wang; Huiming Gao; Ru-Band Lu; Jau-Shyong Hong
Journal:  Mol Neurobiol       Date:  2014-09-14       Impact factor: 5.590

4.  Interactions between innate immunity genes and early-life risk factors in allergic rhinitis.

Authors:  Ju Hee Seo; Hyung Young Kim; Young Ho Jung; Eun Lee; Song I Yang; Ho Sung Yu; Young Joon Kim; Mi Jin Kang; Ha Jung Kim; Kang Seo Park; Ji Won Kwon; Byung Ju Kim; Hyo Bin Kim; Eun Jin Kim; Joo Shil Lee; So Yeon Lee; Soo Jong Hong
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-18       Impact factor: 5.764

Review 5.  T regulatory cells: aid or hindrance in the clearance of disease?

Authors:  Clint A Coleman; Michaela C Muller-Trutwin; Cristian Apetrei; Ivona Pandrea
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

Review 6.  Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis.

Authors:  Simona Iacob; Diana Gabriela Iacob
Journal:  Front Microbiol       Date:  2019-08-07       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.